Rush Enterprise | 8-K: FY2025 Q3 Revenue: USD 1.881 B

Revenue: As of FY2025 Q3, the actual value is USD 1.881 B.

EPS: As of FY2025 Q3, the actual value is USD 0.83.

EBIT: As of FY2025 Q3, the actual value is USD 99.59 M.

Segment Revenue

• New and Used Commercial Vehicle Sales: Revenue was $1,134.9 million for the third quarter of 2025, compared to $1,163.3 million in the third quarter of 2024.
• Parts and Service Sales: Revenue totaled $642.7 million, up from $633.0 million in the third quarter of 2024.
• Lease and Rental: Revenue was $93.3 million, an increase from $89.1 million in the third quarter of 2024.

Operational Metrics

• Net Income: The company reported net income of $66.7 million for the third quarter of 2025, down from $79.1 million in the same period of 2024.
• Gross Profit: Gross profit was $374.8 million, compared to $379.0 million in the third quarter of 2024.
• Operating Income: Operating income was $100.0 million, a decrease from $120.8 million in the third quarter of 2024.
• Selling, General and Administrative Expenses: These expenses increased to $256.4 million from $239.7 million in the third quarter of 2024.

Cash Flow

• Net Cash Provided by Operations: $1,139.6 million for the twelve months ended September 30, 2025, compared to $311.9 million for the same period in 2024.
• Free Cash Flow: $692.0 million for the twelve months ended September 30, 2025, compared to - $72.1 million for the same period in 2024.

Unique Metrics

• Absorption Ratio: The absorption ratio was 129.3% in the third quarter of 2025, compared to 132.6% in the third quarter of 2024.

Outlook / Guidance

• The company expects challenging aftermarket conditions to persist for the remainder of the year, with weak demand due to industry challenges. Despite these challenges, Rush Enterprises believes its diversified customer base and strong balance sheet position it well to navigate these headwinds. The company remains focused on delivering value to customers and solid returns to shareholders, even as market conditions show no signs of significant improvement in the near term.